Gilead, CVS strike deal on Hepatitis C drugs

Shares of Gilead Sciences rise more than 2% Monday after the biotechnology giant scores an exclusive rights deal with the nation’s largest drug-store chain, CVS.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.